| View |
|
BR-754
|
Epoetin Alfa
|
Eposino
|
6,000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shandong Kexing Bioproducts Co., Ltd.
|
China
|
Renewal
|
11 November 2021
|
18 October 2025
|
| View |
|
BR-755
|
Epoetin Alfa (Recombinant Human Erythropoietin)
|
Eposino
|
2,000 IU/mL
|
Solution for Injection (IV/SC)
|
-
|
Shandong Kexing Bioproducts Co., Ltd.
|
China
|
-
|
08 March 2021
|
18 October 2025
|
| View |
|
BR-756
|
Epoetin alfa
|
Eposino
|
4,000 IU/mL
|
Solution For Injection (IV/SC)
|
-
|
Shandong Kexing Bioproducts Co., Ltd.
|
China
|
-
|
11 November 2021
|
18 October 2025
|
| View |
|
BR-76
|
Albumin
|
Plasbumin - 25
|
12.5 g/50 mL (25%)
|
Solution for Injection (IV)
|
-
|
Grifols Therapeutics LLC
|
U.S.A.
|
-
|
12 May 2021
|
09 November 2025
|
| View |
|
BR-769
|
Interferon Alfa-2B (Human)
|
Shaferon
|
6 million I.U./mL
|
Solution For Injection (I.M./S.C.)
|
Immunostimulant
|
Beijing Kawin Technology Share- Holding Co., Ltd.
|
China
|
Renewal
|
29 April 2021
|
19 November 2025
|
| View |
|
BR-770
|
Interferon Alfa-2B (Human)
|
Shaferon
|
5 million I.U/mL
|
Solution For Injection (I.M./S.C.)
|
Immunostimulant
|
Beijing Kawin Technology Share- Holding Co., Ltd.
|
China
|
Renewal
|
30 March 2021
|
19 November 2025
|
| View |
|
BR-771
|
Interferon Alfa-2B (Human)
|
Shaferon
|
3 million I.U/mL
|
Solution For Injection (I.M./S.C.)
|
Immunostimulant
|
Beijing Kawin Technology Share- Holding Co., Ltd.
|
China
|
Renewal
|
30 March 2021
|
19 November 2025
|
| View |
BR-774_PI_01.pdf
|
BR-774
|
Interferon Beta-1A (Human)
|
Rebif
|
132 mcg (36 million I.U.)/1.5 mL
|
Solution for Injection (SC)
|
-
|
Merck Serono S.p.A.
|
Italy
|
-
|
18 February 2021
|
03 January 2026
|
| View |
BR-775_PI_01.pdf
|
BR-775
|
Interferon Beta-1A (Human)
|
Rebif
|
66 mcg (18 million I.U)/1.5 mL
|
Solution For Injection (SC)
|
-
|
Merck Serono S.p.A.
|
Italy
|
-
|
08 March 2021
|
03 January 2026
|
| View |
|
BR-776
|
Rotavirus Vaccine (Live, Attenuated)
|
Rotarix
|
1.5 mL
|
Oral Suspension
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
Renewal
|
23 May 2022
|
18 May 2027
|
| View |
|
BR-778
|
Filgrastim
|
White-C
|
300 mcg/mL
|
Solution For Injection (IV/SC)
|
Immunostimulant
|
Shandong Kexing Bioproducts Co., Ltd.
|
China
|
Renewal
|
30 March 2021
|
11 January 2026
|
| View |
|
BR-779
|
Epoetin Alfa
|
Eposino
|
10,000 IU/mL
|
Solution For Injection (IV/SC)
|
-
|
Shandong Kexing Bioproducts Co., Ltd.
|
China
|
Regular Renewal (Revalidation)
|
24 January 2023
|
18 January 2026
|
| View |
|
BR-783
|
Human Papillomavirus Vaccine [Types 16 and 18]
(Recombinant, adjuvanted, adsorbed)
|
Cervarix
|
Formulation: 1 dose (0.5 mL) contains: Human Papillomavirus type 16 Ll protein*..............20 mcg Human Papillomavirus type 18 L1 protein*... ...........20 mcg
*adjuvanted by AS04 containing 3-O-desacyl-4-monophosphoryl lipid A (MPL) and Aluminum hydroxide, hydrated [Al(OH)3]
|
Suspension for Injection (IM)
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
-
|
27 April 2022
|
23 March 2027
|
| View |
|
BR-789
|
Hepatitis B Immunoglobulin (Human)
|
HyperHEP B S/D
|
(See formulation in reverse side)
|
Solution for Injection (IM)
|
Immunoglobulins
|
Grifols Therapeutivs Inc.
|
United States of America
|
Renewal
|
23 June 2024
|
17 June 2029
|
| View |
|
BR-795
|
Clostridium botulinum Type A Neurotoxin Complex
|
Cunox
|
100units
|
Lyophilized Powder for Injection (IM)
|
Muscle Relaxant
|
Medytox Inc.
|
Korea
|
Renewal
|
23 May 2022
|
19 April 2026
|
| View |
|
BR-797
|
Enoxaparin (as Sodium)
|
Clexane
|
4000 IU (equivalent to 40 mg)/0.4 mL
|
Solution For Injection (S.C.)
|
-
|
Sanofi Winthrop Industrie
|
France
|
Renewal (Correction)
|
29 August 2023
|
15 April 2026
|
| View |
|
BR-798
|
Enoxaparin Sodium
|
Clexane
|
6000 IU (equivalent to 60 mg)/0.6 mL
|
Solution for Injection (S.C.)
|
Antithrombotic Agents
|
Sanofi Winthrop Industrie
|
France
|
Renewal
|
01 June 2021
|
15 April 2026
|
| View |
|
BR-799
|
Enoxaparin (as sodium)
|
Clexane
|
2000 IU (equivalent to 20 mg)/0.2 mL
|
Solution For Injection (S.C.)
|
-
|
Sanofi Winthrop Industrie
|
France
|
Renewal (Correction)
|
29 August 2023
|
15 April 2026
|
| View |
|
BR-80
|
Factor VIII
|
Koate DVI
|
50 I.U./mL (250 I.U./15 mL)
|
Lyophilized Powder for Injection (IV)
|
-
|
Grifols Therapeuitcs, Inc.
|
U.S.A
|
-
|
18 March 2022
|
07 March 2026
|
| View |
|
BR-801
|
Human Tetanus Immunoglobulin
|
Ig Tetano
|
250 IU/mL
|
Solution For Injection (IM)
|
Immunoglobulin
|
Kedrion S.p.A.
|
Italy
|
Renewal
|
30 March 2021
|
20 April 2026
|